IperionX responds to short seller, highlights U.S. contracts and growth plans

IperionX hits back at a short seller report, highlighting fresh U.S. defence contracts and its growth outlook.

| More on:
An old man with wavy white hair folds his arms in a stubborn gesture as he stands defiantly in an outdoor setting.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • IperionX completed the Virginia Titanium Manufacturing Campus commissioning with enhanced production capacity and secured over US$59 million in U.S. Department of Defense awards to expand operations.
  • The company addressed a short seller report, emphasising its robust data-security and compliance controls, along with substantial backing and validation from U.S. Government agencies.
  • IperionX is focused on scaling its operations, increasing titanium production capacity, and advancing the Titan Critical Minerals Project, aiming to penetrate high-growth markets with its innovative titanium products.

The IperionX Ltd (ASX: IPX) share price is in focus today after the company issued a detailed response to a short seller report, reaffirming its operational progress and robust U.S. Government support for its titanium manufacturing technologies.

What did IperionX report?

  • Completion of the Virginia Titanium Manufacturing Campus commissioning, with nameplate production capacity raised to 200 tonnes per annum (tpa)
  • Secured over US$59 million in recent U.S. Department of Defense awards to help expand operations and advance feasibility studies
  • Held US$79.2 million cash and equivalents at 30 September 2025, plus access to US$43 million in obligated government funding
  • Received U.S. Army SBIR Phase III contract for up to US$99 million in procurement, with the first task order already issued
  • Secured commercial agreements with Ford, Panerai, and the U.S. Army for titanium product supply
  • Advancing a pipeline of over 90 active customer programs and 22 final-stage commercial negotiations

What else do investors need to know?

IperionX addressed the short seller's report directly, noting that Spruce Point Capital did not contact or visit management or operational sites before its release. The company emphasised its strong data-security, intellectual property, and compliance controls, meeting U.S. Government requirements.

The business highlighted ongoing support and validation from multiple U.S. Government agencies, including ARPA-E and the Department of Defense, with several funding and production contracts supporting its expansion and commercialisation efforts.

IperionX is scaling its Virginia operations with plans to boost titanium production from the current 200 tpa to approx. 1,400 tpa by mid-2027. Meanwhile, the Titan Critical Minerals Project in Tennessee is progressing towards a definitive feasibility study.

What's next for IperionX?

Management's near-term priorities include increasing production capacity at the Virginia facility, delivering on government task orders, and lowering costs through process improvements. The Titan Project aims to reach shovel-ready status by mid-2026, potentially supplying rare earths, titanium, and zircon to support U.S. critical mineral security.

Looking further ahead, IperionX is targeting high-growth end markets with its low-cost, lower-carbon titanium components, expanding its high-value product offering for sectors such as defence, automotive, and electronics.

IperionX share price snapshot

IperionX shares have risen 38% over the past 12 months, significantly outperforming the S&P/ASX 200 Index (ASX: XJO) which has increased 4% over the same period.

View Original Announcement

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

More on Share Market News

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another red day on the markets this Wednesday.

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Northern Star, Pro Medicus, and Web Travel shares

How does the team at Morgans rate these popular shares? Let's find out.

Read more »

Multiracial happy young people stacking hands outside - University students hugging in college campus - Youth community concept with guys and girls standing together supporting each other.
Share Gainers

Why 4DMedical and these ASX shares are up 200%+ in just a year

These shares have made their shareholders wealthy over the past year.

Read more »

Four people on the beach leap high into the air.
Opinions

4 reasons why I think BHP shares are a must-buy for 2026

The mining giant's shares are now 20% higher than this time last year.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A few gold nullets sit on an old-fashioned gold scale, representing ASX gold shares.
Broker Notes

Up 300% since August, why this surging ASX gold stock could keep racing higher

A leading broker forecasts more strong outperformance from this rocketing ASX gold stock.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Opinions

4DMedical shares crash 20% this week: Should investors cut their losses on the once-booming stock?

The shares are now down 6.61% for the year to date.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why 29Metals, Navigator Global, Praemium, and Xero shares are sinking today

These shares are having a tough time on hump day. But why?

Read more »